glp-1 drugs manufacturers Receptor Agonist Companies and Competitive Landscape GLP-1 Medications for Weight Loss

Key takeaways Ozempic (semaglutide) has several alternatives, including other GLP-1 receptor agonists approved by the US Food and Drug Administration (FDA)

Cost and insurance coverage can also present barriers, particularly when higher dose formulations are prescribed for combined metabolic and cardiovascular benefit

UK consumers should be aware that supplement companies can make structure-function claims without proving they work, unlike prescription medications, which require extensive clinical trials

The transition requires careful dose management to avoid side effects

Other diabetes or weight-loss services that are covered via the respondents extended health plans include: Other prescription/non-GLP-1 drugs56% Nutritional counseling51% Telehealth/virtual care for lifestyle interventions30% Disease management programs/case management29% Telehealth/virtual care for GLP-1 drug treatment17% Lifestyle modification programs12% Bariatric surgery5%

Because GLP-1 RAs reduce appetite and caloric intake, investigators must verify that children achieve adequate nutrition for normal linear growth and pubertal progression